antiarthritic agent

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1950-2017
012319502016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Articular cartilage degeneration and inflammation are the hallmark of progressive arthritis and is the leading cause of… (More)
Is this relevant?
2011
2011
Auranofin is a gold(I)-containing drug in clinical use as an antiarthritic agent. Recent studies showed that auranofin manifests… (More)
  • figure 1
  • table 1
  • figure 3
  • table 2
  • figure 4
Is this relevant?
2009
2009
This paper describes the synthesis and characterization of a composite constituted by an antiarthritic agent (AA) intercalated… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
Electrospray ionisation (ESI) mass spectrometry was used to examine the reactions of the clinically used antiarthritic agent [Au… (More)
  • figure 2
  • figure 3
  • figure 4
  • figure 5
  • figure 7
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Conventional nonsteroidal anti-inflammatory drugs (NSAIDs) nonspecifically inhibit cyclooxygenase-1 (COX-1), an enzyme critical… (More)
Is this relevant?
1986
1986
Auranofin (AF), an orally active, antiarthritic agent, modulates the functional activities of macrophages in vivo and in vitro… (More)
Is this relevant?
1986
1986
A series of gold(I) coordination complexes including analogues of the antiarthritic agent auranofin 1 were evaluated for in vitro… (More)
Is this relevant?
1983
1983
Lobenzarit disodium (CCA) has been reported to have an inhibitory effect on the development of adjuvant arthritis (AA) in rats… (More)
Is this relevant?
1977
1977
Auranofin, an oral chrysotherapeutic agent effective in the treatment of rheumatoid arthritis (RA), was found to be a potent… (More)
  • figure 1
  • figure 3
  • table 2
  • table 3
Is this relevant?